The Lundquist Institute holds both U.S. and international patents for this humanized antibody and has granted Vitalex, a Lundquist spin-off company, the commercial rights to advance this therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback